Peer review reports
From: Serotoninergic receptor ligands improve Tamoxifen effectiveness on breast cancer cells
Original Submission | ||
---|---|---|
1 Feb 2021 | Submitted | Original manuscript |
22 Feb 2021 | Reviewed | Reviewer Report |
24 Feb 2021 | Reviewed | Reviewer Report |
7 Mar 2021 | Reviewed | Reviewer Report |
13 Jun 2021 | Author responded | Author comments - Pietro Formisano |
Resubmission - Version 2 | ||
13 Jun 2021 | Submitted | Manuscript version 2 |
8 Jul 2021 | Author responded | Author comments - Pietro Formisano |
Resubmission - Version 3 | ||
8 Jul 2021 | Submitted | Manuscript version 3 |
27 Jul 2021 | Author responded | Author comments - Pietro Formisano |
Resubmission - Version 4 | ||
27 Jul 2021 | Submitted | Manuscript version 4 |
11 Aug 2021 | Author responded | Author comments - Pietro Formisano |
Resubmission - Version 5 | ||
11 Aug 2021 | Submitted | Manuscript version 5 |
8 Nov 2021 | Reviewed | Reviewer Report |
12 Nov 2021 | Reviewed | Reviewer Report |
Resubmission - Version 6 | ||
Submitted | Manuscript version 6 | |
Publishing | ||
20 Dec 2021 | Editorially accepted | |
15 Feb 2022 | Article published | 10.1186/s12885-021-09147-y |